We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Phase 2a Study Initiated Evaluating RV521 for RSV

News   Sep 05, 2017 | Original story from ReViral Ltd

 
Phase 2a Study Initiated Evaluating RV521 for Respiratory Syncytial Virus Infection
 
 
 

RELATED ARTICLES

Protein “Trafficker” Implicated in Autism and Other Brain Disorders

News

Findings suggest that protein ASTN2 is a key regulator of dynamic trafficking of synaptic proteins and lend support to the idea that aberrant regulation of protein homeostasis in neurons is a contributing cause of complex neurodevelopmental disorders.

READ MORE

Trojan Horse Delivery for Treating Rare Blood-clotting Disorder

News

Platelet blood cells can carry an enzyme needed to prevent clots, while hiding it from autoantibody neutralization.

READ MORE

Simulations Enable 'Choose-your-own-Adventure' Stereochemistry

News

Stereochemistry is a science of reflection. Two chemical molecules with the same composition and structure, but with one as the mirror image of the other, can produce wildly varying effects. But University of Utah chemist Matt Sigman has been developing a way to get a better grasp on this tricky field of chemistry.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE